Instead, AstraZeneca has built one of the industry's strongest oncology franchises through Tagrisso, Imfinzi, Calquence, and Lynparza, and a cardiovascular dominance through Farxiga
Full AI Image Prompt: Create a clean clinical infographic titled GHK-Cu Mechanism and Skin Biology Pathways. Show a central molecular-style icon labeled GHK-Cu complex connected by simple arrows to labeled nodes: Copper ions, Fibroblasts, Collagen synthesis, Extracellular matrix, Glycosaminoglycans, Inflammation pathways, and Wound repair research. Include a small neutral note box that says Mechanism does not prove clinical outcome. Use a professional medical editorial style, white background, subtle blue and copper accents, crisp vector icons, and no product imagery, no syringes, no injection instructions, no dosing visuals, no before-and-after images, and no exaggerated outcome claims
Even with the highest-purity vials available and an optimally designed titration schedule, suboptimal outcomes can arise if the peptide degrades prior to systemic absorption
The downstream effect: restoring the balance between excitatory cholinergic signalling (contract) and inhibitory nitrergic signalling (relax) that controls gastric peristalsis
Inflammation causes an increase in fat deposits, and fat cells cause more inflammation. If not addressed, this can lead to an endless cycle in the body
